相关实验视频

Updated: Apr 11, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

皮肤冠状动脉干预和冠状动脉绕道移植在左侧主要疾病的比较分析通过血管学SYNTAX得分分层分

Abdulwali Abohasan¹, Amin Daoulah², Ahmed Elmahrouk^2,3

¹Department of Cardiology, Hafr Al-Batin Central Hospital, Eastern Province, Kingdom of Saudi Arabia.

|February 19, 2025

概括

单独的SYNTAX评分 (SS) 可能不足以在左主冠状动脉疾病 (LMCA) 中选择皮肤通冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG). 结果因SS而异,但PCI在某些低至中级SS组中显示出比CABG更有利的结果.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
心脏外科手术心脏外科手术

背景情况:

SYNTAX评分 (SS) 用于指导左主冠状动脉疾病 (LMCA) 的重血管化决策.
它在穿皮冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG) 之间进行选择的唯一实用性仍在调查中.

研究的目的:

研究由SS.分层的LMCA重血管化的临床结果.
评估SS在确定最佳再血管化策略 (PCI与CABG) 中的作用.

主要方法:

一项多中心研究包括2138名在2015-2020年期间接受LMCA重血管化 (PCI或CABG) 的患者.
患者被分为低 (≤22),中等 (23-32) 和高 (≥33) 的SS组.
分析了包括医院死亡率和重大心脏和脑血管事件 (MACCE) 在内的临床结果.

主要成果:

与中级SS患者相比,高SS患者的医院死亡率和MACCE增加.
在高和中等SS组之间没有观察到随访MACCE或死亡率的显著差异.
在低至中等SS类别的医院MACCE中,显著的相互作用有利于PCI而不是CABG.

结论:

单独的SYNTAX评分可能不足以选择LMCA复血管化方式.
在早期的MACCE方面,PCI可能在特定的SS层中比CABG提供优势.
需要进一步的研究来完善LMCA疾病治疗的决策算法.

关键词:

根据CABG的规定.马克斯 (Macce) 是一个马克斯.这是PCI的PCI.在SYNTAX中,分数是SYNTAX的分数.左侧主要冠状动脉疾病死亡率死亡率

更多相关视频

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

相关概念视频

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...